Analysts Are Neutral on Top Materials Stocks: Ivanhoe Mines (IVPAF), Sociedad Quimica Y Minera SA (SQM)
Analysts fell to the sidelines weighing in on Ivanhoe Mines (IVPAF) and Sociedad Quimica Y Minera SA (SQM) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Ivanhoe Mines (IVPAF)
In a report released today, Fahad Tariq from Jefferies maintained a Hold rating on Ivanhoe Mines, with a price target of C$13.00. The company’s shares closed last Wednesday at $8.48, close to its 52-week low of $8.38.
According to TipRanks.com, Tariq is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ivanhoe Mines with a $10.16 average price target.
See today’s best-performing stocks on TipRanks >>
Sociedad Quimica Y Minera SA (SQM)
In a report released yesterday, Marcio Farid from Goldman Sachs maintained a Hold rating on Sociedad Quimica Y Minera SA, with a price target of $64.00. The company’s shares closed last Wednesday at $83.94.
According to TipRanks.com, Farid is a 5-star analyst with an average return of
Currently, the analyst consensus on Sociedad Quimica Y Minera SA is a Hold with an average price target of $82.63, a 5.9% upside from current levels. In a report issued on May 23, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $86.00 price target.
Read More on IVPAF:
Disclaimer & DisclosureReport an Issue
- Ivanhoe Mines price target lowered to C$13 from C$13.50 at Scotiabank
- IVPAF Earnings this Week: How Will it Perform?
- Ivanhoe Mines price target raised to C$12 from C$11.50 at Canaccord
- Ivanhoe Mines price target lowered to C$13.50 from C$14.50 at Scotiabank
- Ivanhoe Mines: Operational Resilience, By‑Product Margin Upside, and Underappreciated Growth Support Buy Rating
